Selecting the right biomarkers is important for success in phase transition of clinical trials. Spatial phenotyping has increasingly allowed us to select high-quality protein biomarkers that correlate more strongly with patient outcomes. There is a growing need to identify high-quality protein biomarkers to support clinical research, and spatial biology is showing promise in providing these answers.
This webcast will present the use of a 51-plex panel that covers a range of functional and tumor microenvironment-related biomarkers, including lymphoid and myeloid cell markers, tissue biomarkers, antigen presenting cells, and immune checkpoint and activation markers. Analyzing this comprehensive panel of biomarkers identifies cell types that are up or downregulated in different disease states. Further, exploring the spatial relationships between cells uncovers important differences in cell-to-cell interactions and neighborhoods between disease states. These spatial analyses offer a powerful toolkit for discovering key biomarkers in various diseases and treatments.
You will learn:
• What insights can be gained from spatial analysis of tissue?
• What cellular subtypes, neighborhoods, and cell-cell interactions are predictive of response to a targeted therapy and to delineate disease severity?
• Which pathways should we be more deeply interrogating and drugging given their link to disease progression?
Unable to join the live event? Watch on demand. Register now to ensure that you receive information on how to gain access after the live event.
This webcast has been produced by Akoya Biosciences, who retails sole responsibility for content. About this content.
Speaker
Aaron Mayer, CSO, Enable Medicine
Aaron received his Ph.D. in Bioengineering from Stanford University, where he developed molecular imaging tools, including novel software, hardware, and wetware. At Enable Medicine, he and his team are developing cartography tools that enable researchers, drug developers, and physicians to explore disease at the cellular level, navigate patient care, and discover new drugs.
Moderator
Sarah Hiddleston, Nature Research Custom Media
Sarah Hiddleston is a freelance journalist who has worked with Nature Research Custom Media since 2015. Previously, Sarah worked for a decade in Madras (Chennai), India, specialising in health, pharmaceutical and environmental stories. Sarah holds an MA in Investigative Journalism from City University London, an MSc in Political Theory from the London School of Economics, and an undergraduate degree in History from the University of Cambridge, UK.
